Dendrite Buys Optas for $12 Million

Share this article:
Dendrite International Inc., a provider of sales, marketing and clinical solutions for the pharmaceutical industry, said yesterday that it has acquired Optas Inc. for $12 million.


Founded in 1997, Optas is a privacy-safe database marketing software and services company serving the pharmaceutical and health industries. Optas will become a division of Dendrite International, which is based in Bedminster, NJ.


Dendrite and Optas are already deployed together in a large pharmaceutical company where Optas enables physicians to direct patients into an educational program, and Dendrite provides a personalized patient medical support center where patients speak to medical professionals who complement and support the prescribing doctor's own initiatives. Both elements are orchestrated through Optas' campaign management tool.


Share this article:
close

Next Article in Data/Analytics

Sign up to our newsletters

Follow us on Twitter @dmnews

Latest Jobs:

Featured Listings

More in Data/Analytics

AmEx Veteran Takes COO Role at Acxiom

AmEx Veteran Takes COO Role at Acxiom

Kerry Hatch ran American Express's OPEN business card division and led units at Starwood and Time Inc.

Red Roof Inn Turns Weather Woes Into Major Sales

Red Roof Inn Turns Weather Woes Into Major ...

The hotel chain woos stranded airline passengers with deals based on flight cancellations.

Signal Wants to Help CMOs Put Vendors to the Test

Signal Wants to Help CMOs Put Vendors to ...

The company claims its new Signal Tag can quintuple the number of A/B vendor tests marketers can do each year.